News
Concept Medical Group, a global leader in drug-eluting technologies, has been awarded the prestigious Times Healthcare ...
Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...
New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted in 2019 Company nears start of Registrational Phase 3 study targeted at an ...
and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of ...
Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted ...
9) Sobi and Cartesian Therapeutics/Selecta Biosciences' SEL-212 (nanoparticle encapsulated sirolimus and pegylated uricase), a novel, once-monthly treatment for gout that could overcome the ...
From decoy DNA sequences to plasmapheresis, researchers are testing strategies to get around anti-AAV antibodies that hinder ...
Early work showed that the addition of the antibody surface modification allowed for the maintenance of the antiproliferative effects of sirolimus while also enhancing the endothelial growth over the ...
FDA Breakthrough Device Designation Awarded to AVIM Therapy FDA IDE Approved for Virtue SAB U.S. Pivotal Trial for Launch NEW HOPE, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc ...
Forty-six oral medications communly used in hospitalized patients were evaluated. Study investigators identified these medications as the formulary medications most frequently prescribed in the ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ISOPTIN injection contains the active ingredient verapamil ...
Orchestra BioMed is sponsoring and in full operational control of the Virtue Trial; mediation with Terumo of certain other contractual terms is progressing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results